Journal articleCancer Res2026
KRAS Signaling Inhibition Induces a Targetable Metabolic Dependency on Lipophagy-Dependent Fatty Acid Oxidation in Pancreatic Cancer.
- Journal
- Cancer Res
- Published
- 1 July 2026
- Citations
- 5
- Type
- Article
- License
- cc by-nc-nd
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Grants 14
- Project 3: Mechanisms and therapeutic targeting of NRAS in melanoma P01CA203657↗
- Targets, Modulators and Delivery Program P30CA036727↗
- Pancreas Cancer Specific Probe for Image Guided Resection P30CA225520↗
- Project 1: Overcoming Tumor-Induced Immune Suppression to Improve Responses to Immunotherapy P50CA196510↗
- SToP Cancer SPORE: Administrative Core A P50CA257911↗
- Biological Activity of Ras Oncogenes R01CA042978↗
- Targeting Tumor-Stromal Metabolic Cross-Talk in Pancreatic Cancer R01CA163649↗
- Targeting the Metabolic Basis of Cachexia in Pancreatic Cancer R01CA210439↗
- Mitochondrial calcium signaling in pancreatic cancer metastasis and progression R01CA256911↗
- Molecular Basis of ME2-mediated Tumor Suppression in Pancreatic Cancer R01CA270234↗
- Targeting undruggable RAS for cancer treatment R35CA232113↗
- Vitamin B6 Modulates NK Cell Metabolism in Pancreatic Cancer R37CA276924↗
- Identification of synthetic lethal interactors in pancreatic cancer U01CA199235↗
- MUC1 in Therapy Resistance U54CA274329↗